PIERUZZI FEDERICO UMBERTO EMILIO GUGLIE

Lanfranconi, F., Peli, L., Pollastri, L., Ferri, A., Tremolizzo, L., Conti, E., et al. (2026). Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type III. PHYSIOLOGICAL REPORTS, 14(4 (February 2026)) [10.14814/phy2.70771]. Dettaglio

Camporeale, A., De Angeli, G., Guida, G., Pieruzzi, F., Econimo, L., Lusardi, P., et al. (2026). Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD). INTERNATIONAL JOURNAL OF CARDIOLOGY, 444(February 01, 2026) [10.1016/j.ijcard.2025.134011]. Dettaglio

Lentini, P., Bianchi, S., Viglino, G., Pieruzzi, F., Grandaliano, G., Pesce, F., et al. (2026). Transforming chronic kidney disease care with telemedicine: expert consensus recommendations from the Italian Society of Nephrology. JN. JOURNAL OF NEPHROLOGY, 39(1), 12-25 [10.1093/joneph/aajaf007]. Dettaglio

Cazzaniga, G., Carbone, M., Barretta, R., Casati, G., Vatrano, S., Gambaro, G., et al. (2026). Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy. SCIENTIFIC REPORTS, 16(1) [10.1038/s41598-026-35466-w]. Dettaglio

Camporeale, A., Guida, G., Pieroni, M., Pieruzzi, F., Lusardi, P., Ferraresi, M., et al. (2026). Prognostic role of myocardial storage, hypertrophy, and inflammation/fibrosis in Fabry cardiomyopathy: a new predictive score including T1 values. EUROPEAN HEART JOURNAL. QUALITY OF CARE & CLINICAL OUTCOMES, 12(3 (May 2026)), 344-354 [10.1093/ehjqcco/qcaf154]. Dettaglio